| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002115A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |
| 01/10/2002 | WO2002002098A2 Antibacterial method and composition with phenolic compounds |
| 01/10/2002 | WO2002002089A2 Anthelmintics for preventing parasitic infections in humans and animals |
| 01/10/2002 | WO2002002050A2 Prevention and treatment of mycoplasma-associated diseases |
| 01/10/2002 | WO2002001953A1 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004486 Miticides, parasiticides; veterinary medicine |
| 01/10/2002 | CA2414690A1 Anthelmintics for preventing parasitic infections in humans and animals |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412830A1 Antibacterial method and composition with phenolic compounds |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169328A2 Avermectin derivatives |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP1169030A1 Agents and methods for promoting production gains in animals |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP1169005A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 01/09/2002 | EP1168931A1 Method of using emamectin to treat fish parasites |
| 01/09/2002 | EP1168920A1 (s)-enantiomer enriched fipronil composition |
| 01/09/2002 | CN1330660A Cycle tetrapeptide compound and their use |
| 01/09/2002 | CN1330553A Adjuvant systems and vaccines |
| 01/09/2002 | CN1330540A Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/03/2002 | WO2002102789A1 Antimicrobial and radioprotective compounds |
| 01/03/2002 | WO2002002088A2 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 01/03/2002 | WO2002000839A2 Statement as to federally sponsored research |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000266A2 A method of treating and preventing infectious diseases |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | US20020002296 Cytoprotective Compounds |
| 01/03/2002 | US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 01/03/2002 | DE10031044A1 Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere Endoparasiticides means of voluntary oral ingestion by animals |
| 01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
| 01/03/2002 | CA2415236A1 Novispirins: antimicrobial peptides |
| 01/03/2002 | CA2414678A1 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167376A1 Macrolide antibiotics |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165617A2 Anti-plasmodium compositions and methods of use |
| 01/02/2002 | EP1165598A1 Hookworm platelet inhibitor |
| 01/02/2002 | EP1165573A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/02/2002 | EP1165565A1 Optically pure camptothecin analogues |
| 01/02/2002 | EP1165527A1 Pesticidal enantiomer-pure 2,4-disubstituted oxazolines |
| 01/02/2002 | EP1165140A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 01/02/2002 | EP1165132A2 Dry formulation for transcutaneous immunization |
| 01/02/2002 | EP1165124A1 Recombinant neospora antigens and their uses |
| 01/02/2002 | EP1165073A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 01/02/2002 | EP1165043A1 Drinkable pharmaceutical solution |
| 01/02/2002 | EP0871630B1 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO 3,4':4,5]FURO(3,2-b)PYRIDINE-6,8 7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES |
| 01/02/2002 | CN1329617A Hygromycin A derivatives as antibacterial agents |
| 01/02/2002 | CN1329600A Method for control of arthropods in animals |
| 01/02/2002 | CN1328832A Preparation method of fowl and livestock medicine Qiuchongqing |
| 01/01/2002 | US6335427 Component of stem bromelain |
| 01/01/2002 | US6335363 Administering 4-(sulfonylamino-)-chromane derivative as insecticide, nematocide, fungicide or pesticide for crop protection |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098364A2 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098357A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001097836A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | WO2001097753A2 Novel methods using pyridine derivatives |
| 12/27/2001 | WO2001051608A3 Hybrid cells obtainable from antigen presenting cells |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010055598 Mixture with solvent and hydrophobic carrier |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2411912A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/26/2001 | CN1328563A Organophosphorous compounds and use thereof |
| 12/26/2001 | CN1328465A Use of phosphonoformic acid derivatives for treating infections |
| 12/26/2001 | CN1328464A Use of phosphonoformic acid derivatives for treating infections |
| 12/26/2001 | CN1327815A Chinese medicine for preventing and treating coccidiosis of domestic fowls and its preparing process |
| 12/25/2001 | CA2027023C Inosine/guanosine derivatives |
| 12/20/2001 | WO2001096547A2 Human kinases |